Home › Macular Degeneration › Indiana
Macular Degeneration clinical trials in Indiana
7 studies for Macular Degeneration are looking for participants at sites in Indiana.
Cities in Indiana
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
- Associated Vitreoretinal and Uveitis Consultants, Carmel
- Midwest Eye Institute, Carmel
RecruitingPhase 2/3
Ages 50 and older · All sexes · Updated Oct 2, 2026 · NCT07440225A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Midwest Eye Institute, Carmel
RecruitingPhase 2/3
Ages 60 and older · All sexes · Updated Sep 30, 2026 · NCT06635148Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Retina Partners Midwest, P.C., Carmel
RecruitingPhase 2
Ages 55 and older · All sexes · Updated Sep 10, 2026 · NCT066594454D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
- Retina Partners Midwest, Carmel
RecruitingPhase 1/2
Ages 50 and older · All sexes · Updated Aug 21, 2026 · NCT05197270Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
- Retina Partners Midwest, P.C. /ID# 262172, Carmel
RecruitingPhase 1/2
Ages 50 and older · All sexes · Updated Jul 13, 2026 · NCT07160179Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
- Retina Partners Midwest, PC, Carmel
RecruitingPhase 3
Ages 50 and older · All sexes · Updated Apr 16, 2026 · NCT07064759Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration
- CBCC Global Research Site:004, Carmel
RecruitingPhase 1
Ages 50 and older · All sexes · Updated Feb 7, 2025 · NCT06132035From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.